Vertex Pharmaceuticals (VRTX)
NASDAQ: VRTX
· Real-Time Price · USD
392.65
2.35 (0.60%)
At close: Aug 15, 2025, 3:42 PM
Vertex Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.38B | 4.67B | 4.57B | 5.24B | 4.58B | 9.16B | 10.37B | 11.11B | 10.15B | 9.29B | 10.5B | 9.17B | 8.7B | 7.6B | 6.79B | 6.28B | 6.06B | 6.3B |
Short-Term Investments | 1.41B | 1.53B | 1.55B | 1.29B | 1.22B | 1.01B | 849.2M | 818M | 1.09B | 1.12B | 274.5M | 599.2M | 551.2M | 638M | 729.9M | 685.19M | 644.32M | 619.64M |
Long-Term Investments | 5.65B | 5.16B | 5.11B | 4.7B | 4.39B | 4.38B | 2.5B | 1.7B | 1.36B | 1.08B | 112.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.08B | 1.01B | 999.3M | 990.2M | 915.6M | 875.7M | 895.3M | 475.2M | 442.7M | 427.5M | 409.6M | 132.5M | 127.3M | 110.7M | 110.8M | 75.52M | 71.1M | 49.26M |
Receivables | 1.89B | 1.81B | 1.61B | 1.75B | 1.66B | 1.79B | 1.56B | 1.54B | 1.56B | 1.55B | 1.44B | 1.39B | 1.33B | 1.29B | 1.14B | 1.1B | 929.14M | 977.55M |
Inventory | 1.5B | 1.36B | 1.21B | 1.08B | 914.6M | 813.1M | 738.8M | 688.7M | 603.5M | 535.1M | 460.6M | 388.2M | 367.7M | 338.9M | 353.1M | 333.46M | 321.62M | 298.86M |
Other Current Assets | 652.3M | 642.8M | 206.5M | 449.2M | 575.4M | 511.1M | 86.1M | 540.2M | 476.9M | 468.7M | 121.9M | n/a | n/a | n/a | 103.7M | n/a | n/a | n/a |
Total Current Assets | 10.43B | 10.01B | 9.6B | 9.8B | 8.94B | 13.29B | 14.14B | 14.7B | 13.87B | 12.97B | 13.23B | 12.27B | 11.5B | 10.36B | 9.56B | 8.85B | 8.46B | 8.54B |
Property-Plant & Equipment | 2.65B | 2.63B | 2.58B | 2.51B | 1.77B | 1.49B | 1.45B | 1.43B | 1.45B | 1.45B | 1.46B | 1.46B | 1.42B | 1.44B | 1.42B | 1.35B | 1.34B | 1.31B |
Goodwill & Intangibles | 1.52B | 1.53B | 1.91B | 1.92B | 1.93B | 1.92B | 1.93B | 1.69B | 1.69B | 1.69B | 1.69B | 1.68B | 1.39B | 1.4B | 1.4B | 1.4B | 1.4B | 1.4B |
Total Long-Term Assets | 13.61B | 12.87B | 12.94B | 12.44B | 11.19B | 10.63B | 8.59B | 7.03B | 6.48B | 6.01B | 4.92B | 4.44B | 4.08B | 3.89B | 3.87B | 3.77B | 3.76B | 3.58B |
Total Assets | 24.04B | 22.88B | 22.53B | 22.24B | 20.13B | 23.92B | 22.73B | 21.73B | 20.35B | 18.97B | 18.15B | 16.71B | 15.58B | 14.26B | 13.43B | 12.62B | 12.22B | 12.12B |
Account Payables | 3.71B | 445M | 413M | 395.8M | 327.9M | 351.4M | 364.9M | 375.9M | 363M | 323.2M | 303.9M | 126.9M | 198M | 173.6M | 195M | 127.86M | 127.53M | 127.84M |
Deferred Revenue | n/a | n/a | 206.8M | n/a | n/a | n/a | 170.3M | n/a | n/a | n/a | 159.6M | n/a | n/a | n/a | 171.7M | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 92.3M | n/a | n/a | n/a | 83.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -3.29B | 386.4M | -60.9M | 357.6M | 279.3M | 648.6M | 189.5M | 316.2M | 391M | 377M | 62.5M | 218M | 238.7M | 286.1M | 16.5M | 201.41M | 226.36M | 284.17M |
Total Current Liabilities | 4.14B | 3.78B | 3.56B | 3.97B | 3.55B | 3.8B | 3.55B | 3.6B | 3.35B | 3.03B | 2.74B | 2.61B | 2.56B | 2.18B | 2.14B | 1.91B | 1.84B | 1.94B |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.2B | 951.9M | 901.8M | 933.3M | 876.8M | 853.6M | 877.7M | 869.3M | 759.3M | 726.5M | 685.8M | 242.9M | 245.2M | 296.4M | 303.3M | 296.97M | 294.99M | 291.96M |
Total Long-Term Liabilities | 2.72B | 2.6B | 2.56B | 2.64B | 1.81B | 1.57B | 1.6B | 1.61B | 1.53B | 1.52B | 1.5B | 1.07B | 1.09B | 1.17B | 1.19B | 1.17B | 1.19B | 1.19B |
Total Liabilities | 6.86B | 6.38B | 6.12B | 6.61B | 5.36B | 5.37B | 5.15B | 5.21B | 4.88B | 4.54B | 4.24B | 3.68B | 3.65B | 3.35B | 3.33B | 3.09B | 3.03B | 3.13B |
Total Debt | 1.53B | 1.65B | 1.75B | 1.7B | 933.4M | 721.3M | 808.4M | 744.7M | 767.6M | 789.2M | 899.7M | 824.6M | 847.3M | 872.5M | 967.4M | 876.8M | 893.85M | 898.8M |
Common Stock | 256.3M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.6M | 2.5M | 2.56M | 2.59M | 2.59M |
Retained Earnings | 16.92B | 10.25B | 9.61B | 8.69B | 7.65B | 11.24B | 10.14B | 9.17B | 8.14B | 7.22B | 6.52B | 5.7B | 4.77B | 3.96B | 3.2B | 2.43B | 1.58B | 1.51B |
Comprehensive Income | -101.1M | 68.1M | 127.8M | 28.8M | 22.5M | 17.3M | -14.3M | -3M | -39.8M | -13.1M | 800K | 97.6M | 57.5M | 11.3M | 15.9M | 11.54M | -25.16M | -33.3M |
Shareholders Equity | 17.18B | 16.5B | 16.41B | 15.63B | 14.77B | 18.55B | 17.58B | 16.51B | 15.47B | 14.43B | 13.91B | 13.03B | 11.93B | 10.91B | 10.1B | 9.53B | 9.2B | 8.98B |
Total Investments | 5.65B | 6.68B | 6.65B | 5.99B | 5.61B | 5.39B | 3.35B | 2.52B | 2.44B | 2.21B | 386.7M | 599.2M | 551.2M | 638M | 729.9M | 685.19M | 644.32M | 619.64M |